WUXI BIO (02269) has announced a significant share repurchase operation conducted on June 18, 2026.

The company allocated a substantial HK$99.735 million to buy back 3.26 million of its own shares on that date.

In a separate corporate action, the firm also issued 12,000 new shares on June 18, 2026. These shares were issued to fulfill the exercise of options under a pre-IPO share option scheme that was initially adopted on January 5, 2016, and subsequently amended on August 10, 2016.